Sanofi
SAN.PAFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
46,500
Cost of Revenue
13,855
Gross Profit
32,646
Gross Margin
70.2%
Operating Income
15,173
Operating Margin
32.6%
Net Income
5,838
Net Margin
12.6%
EPS (Basic)
$5.00
EPS (Diluted)
$5.00
EBITDA
12,247
EBITDA Margin
26.3%
2023
12/31/2023
Revenue
43,164
Cost of Revenue
13,250
Gross Profit
29,915
Gross Margin
69.3%
Operating Income
13,629
Operating Margin
31.6%
Net Income
5,670
Net Margin
13.1%
EPS (Basic)
$5.00
EPS (Diluted)
$5.00
EBITDA
11,630
EBITDA Margin
26.9%
2022
12/31/2022
Revenue
42,319
Cost of Revenue
12,462
Gross Profit
29,857
Gross Margin
70.6%
Operating Income
13,806
Operating Margin
32.6%
Net Income
8,790
Net Margin
20.8%
EPS (Basic)
$6.00
EPS (Diluted)
$6.00
EBITDA
13,748
EBITDA Margin
32.5%
2021
12/31/2021
Revenue
41,134
Cost of Revenue
12,864
Gross Profit
28,270
Gross Margin
68.7%
Operating Income
8,532
Operating Margin
20.7%
Net Income
6,534
Net Margin
15.9%
EPS (Basic)
$5.00
EPS (Diluted)
$5.00
EBITDA
11,814
EBITDA Margin
28.7%
2020
12/31/2020
Revenue
39,237
Cost of Revenue
12,711
Gross Profit
26,526
Gross Margin
67.6%
Operating Income
14,819
Operating Margin
37.8%
Net Income
12,909
Net Margin
32.9%
EPS (Basic)
$10.00
EPS (Diluted)
$10.00
EBITDA
10,989
EBITDA Margin
28.0%